Trial efficacy and safety data do not transfer to an unverified product
kidney and prostate declined somewhat
Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study
They slow the rate at which food moves through the stomach and intestines
Read More GLP1 medications increase your risk of dehydration because you eat less food, experience GI side effects, and may not feel as thirsty
Obesity as well as type 2 diabetes are chronic conditions, so typically once a medication is started, its not stopped unless its replaced with something else